Skip to main content
SpringerLink
Log in

Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway

  • Original Article
  • Published:
Tumor Biology

Abstract

This study is designated to investigate the roles of cyclin Y (CCNY) and Wnt signaling pathway in regulating ovarian cancer (OC) cell proliferation, migration, and invasion. Quantitative real-time PCR (qRT-PCR), Western blot, MTT assay, cell scratch, and transwell test were used in our study, and transplanted tumor model was constructed on nude mice. C-Myc, cyclin D1, PFTK1, ki67, OGT, and β-catenin protein expressions in tumor tissues were detected. CCNY was significantly upregulated in OC cell lines and tissues (both P < 0.05); significant association was observed between CCNY expression and clinicopathological stage, lymph node metastasis (LNM) (P < 0.05); and the CCNY expression in stages III to IV was higher than that in stages I to II, and patients with LNM had higher CCNY expression when compared with those in patients without LNM (P < 0.05); expressions of c-Myc, cyclin D, PFTK1, ki67, and OGT were upregulated in OC tissues compared with ovarian benign tissues, suggesting that these expressions were significantly different between the two groups (P < 0.05); CCNY significantly exacerbated proliferation, migration, and invasion of A2780 cells; c-Myc and cyclin D1 protein expressions increased as the expression of CCNY increased (P < 0.001); β-catenin expressions in A2780 cells with over-expression of CCNY were significantly increased in the nucleus, but significantly decreased in the cytoplasm (both P < 0.05); high expressions of CCNY exacerbated the proliferation of A2780 cells in nude mice and significantly increased c-Myc, cyclin D1, PFTK1, ki67, and OGT protein expressions in tumor tissues which were transplanted into nude mice (P < 0.01). CCNY might exacerbate the proliferation, migration, and invasion of OC cells via activating the Wnt signaling pathway. Thus, this study provides a theoretical foundation for the development of therapeutic drugs that are able to cure OC by targeting CCNY.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Gao L, Ye X, Ma RQ, Cheng HY, Han HJ, Cui H, et al. Low programmed cell death 5 expression is a prognostic factor in ovarian cancer. Chin Med J (Engl). 2015;128(8):1084–90.

    Article  Google Scholar 

  2. Liu J, Matulonis UA. New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances. Clin Cancer Res. 2014;20(20):5150–6.

    Article  CAS  PubMed  Google Scholar 

  3. Gao J, Yang X, Zhang Y. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies. Jpn J Clin Oncol. 2015;45(1):49–60.

    Article  PubMed  Google Scholar 

  4. Quitadamo A, Tian L, Hall B, Shi X. An integrated network of microRNA and gene expression in ovarian cancer. BMC Bioinformatics. 2015;16 Suppl 5:S5.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liu H, Yan ZQ, Li B, Yin SY, Sun Q, Kou JJ, et al. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/beta-catenin signaling pathway. J Ovarian Res. 2014;7:87.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mostowska A, Pawlik P, Sajdak S, Markowska J, Pawalowska M, Lianeri M, et al. An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population. Mol Diagn Ther. 2014;18(1):85–91.

    Article  CAS  PubMed  Google Scholar 

  7. Jiang M, Gao Y, Yang T, Zhu X, Chen J. Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett. 2009;583(13):2171–8.

    Article  CAS  PubMed  Google Scholar 

  8. Cho E, Kim DH, Hur YN, Whitcomb DJ, Regan P, Hong JH, et al. Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP. Sci Rep. 2015;5(12):624.

    Google Scholar 

  9. An W, Zhang Z, Zeng L, Yang Y, Zhu X, Wu J. Cyclin Y is involved in the regulation of adipogenesis and lipid production. PLoS One. 2015;10(7):e0132721.

    Article  PubMed  PubMed Central  Google Scholar 

  10. D’Addabbo A, Palmieri O, Maglietta R, Latiano A, Mukherjee S, Annese V, et al. Discovering genetic variants in Crohn’s disease by exploring genomic regions enriched of weak association signals. Dig Liver Dis. 2011;43(8):623–31.

    Article  PubMed  Google Scholar 

  11. Yue W, Zhao X, Zhang L, Xu S, Liu Z, Ma L, et al. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis. Clin Lung Cancer. 2011;12(1):43–50.

    Article  CAS  PubMed  Google Scholar 

  12. Ma L, Yue W, Teng Y, Zhang L, Gu M, Wang Y. Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma. Dis Markers. 2013;35(5):317–25.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sun T, Co NN, Wong N. PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma. Biochem Biophys Res Commun. 2014;449(1):163–8.

    Article  CAS  PubMed  Google Scholar 

  14. Ford CE, Jary E, Ma SS, Nixdorf S, Heinzelmann-Schwarz VA, Ward RL. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. PLoS One. 2013;8(1):e54362.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. M PN. World Medical Association publishes the revised declaration of Helsinki. Natl Med J India. 2014;27(1):56.

    PubMed  Google Scholar 

  16. Zhao X, Jiang M, Yue W. The function and molecular mechnism of cyclin Y protein. Zhongguo Fei Ai Za Zhi. 2013;16(11):605–8.

    CAS  PubMed  Google Scholar 

  17. Tai J, Li AD, Rao YS, Huang YB, Huang ZG, Yu ZK, et al. Influence on cell proliferation by small interfering RNA of Cyclin Y expression in laryngeal cancer cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013;48(9):761–4.

    PubMed  Google Scholar 

  18. Xu Y, Wang Z, Wang J, Li J, Wang H, Yue W. Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Oncol Res. 2010;18(8):359–64.

    Article  PubMed  Google Scholar 

  19. Fan S, Zhao C, Zhang L, Dai S, Ren J, Zhang X, et al. Knockdown of PFTK1 inhibits the migration of glioma cells. J Mol Neurosci. 2015;57(2):257–64.

    Article  CAS  PubMed  Google Scholar 

  20. Miyagaki H, Yamasaki M, Miyata H, Takahashi T, Kurokawa Y, Nakajima K, et al. Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma. Br J Cancer. 2012;106(5):947–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Battista MJ, Mantai N, Sicking I, Cotarelo C, Weyer V, Lebrecht A, et al. Ki-67 as an independent prognostic factor in an unselected cohort of patients with ovarian cancer: results of an explorative, retrospective study. Oncol Rep. 2014;31(5):2213–9.

    PubMed  Google Scholar 

  22. Liu P, Sun YL, Du J, Hou XS, Meng H. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer. Int J Gynecol Cancer. 2012;22(4):586–92.

    Article  PubMed  Google Scholar 

  23. Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, et al. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 2013;73(16):5277–87.

    Article  CAS  PubMed  Google Scholar 

  24. Krzeslak A, Forma E, Bernaciak M, Romanowicz H, Brys M. Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin Exp Med. 2012;12(1):61–5.

    Article  CAS  PubMed  Google Scholar 

  25. Liu D, Guest S, Finley Jr RL. Why Cyclin Y? A highly conserved cyclin with essential functions. Fly (Austin). 2010;4(4):278–82.

    Article  Google Scholar 

  26. Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol. 2010;20(8):453–60.

    Article  CAS  PubMed  Google Scholar 

  27. Davidson G, Shen J, Huang YL, Su Y, Karaulanov E, Bartscherer K, et al. Cell cycle control of Wnt receptor activation. Dev Cell. 2009;17(6):788–99.

    Article  CAS  PubMed  Google Scholar 

  28. Huang H, He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol. 2008;20(2):119–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development. 2009;136(19):3205–14.

    Article  PubMed  Google Scholar 

  30. Davidson G. The cell cycle and Wnt. Cell Cycle. 2010;9(9):1667–8.

    Article  CAS  PubMed  Google Scholar 

  31. Koehler A, Schlupf J, Schneider M, Kraft B, Winter C, Kashef J. Loss of Xenopus cadherin-11 leads to increased Wnt/beta-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. Dev Biol. 2013;383(1):132–45.

    Article  CAS  PubMed  Google Scholar 

  32. Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest. 2009;27(6):604–12.

    Article  CAS  PubMed  Google Scholar 

  33. Hendaoui I, Tucker RP, Zingg D, Bichet S, Schittny J, Chiquet-Ehrismann R. Tenascin-C is required for normal Wnt/beta-catenin signaling in the whisker follicle stem cell niche. Matrix Biol. 2014;40:46–53.

    Article  CAS  PubMed  Google Scholar 

  34. Li X, Chen C, Wang F, Huang W, Liang Z, Xiao Y, et al. KCTD1 suppresses canonical Wnt signaling pathway by enhancing beta-catenin degradation. PLoS One. 2014;9(4):e94343.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to express our sincere appreciation to the reviewers for their constructive comments on this article.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Dongcheng District, Beijing, 100730, China

    Haiyuan Liu, Honghui Shi & Qingbo Fan

  2. Department of Obstetrics and Gynecology, Linyi People’s Hospital, Linyi, 276003, Shandong, China

    Xiangxiu Sun

Authors
  1. Haiyuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Honghui Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qingbo Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiangxiu Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haiyuan Liu.

Ethics declarations

The experimental protocol was approved by the Ethics Committee of Animal Experiment Center of Peking Union Medical College Hospital and complied with the standards with respect to animal experiment published by the US National Institutes of Health in 1996.

Conflicts of interest

None

Ethics approval and informed consent

This study was approved by the ethics committee of Peking Union Medical College Hospital, and all patients signed the informed consent. The implementation of this study complied with the standards set by the Declaration of Helsinki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, H., Shi, H., Fan, Q. et al. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway. Tumor Biol. 37, 10161–10175 (2016). https://doi.org/10.1007/s13277-016-4818-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-4818-3

Keywords

Search

Navigation